BioSpace News Archive

Business

Progenics Pharmaceuticals Appoints David Mims as Interim Chief Executive Officer

David W. Mims as interim Chief Executive Officer. Mr. Mims, a member of Progenics’ Board of Directors, will assume the leadership of the executive team while the Board of Directors conducts a search to identify a permanent Chief Executive Officer.

November 21, 2019
·
5 min read
Pharm Country

Nabriva Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 4:30 p.m. ET. The conference is being held at the Lotte New York Palace in New York, NY.

November 21, 2019
·
4 min read
Genetown

Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference

Lantheus Holdings, Inc. announced Mary Anne Heino, President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference at 9:30 a.m. ET on Thursday, December 5 in New York.

November 21, 2019
·
1 min read
Biotech Beach

Can Fecal Microbiota Transplant (FMT) Aid in Cancer Treatment?

Doctors share hopeful results with FMT as adjunct therapy to standard-of-care Cancer treatments at MIBIOC Milan, Italy. MIBIOC is the first international conference dedicated to the microbiota in cancer and features expert speakers from around the world.

November 21, 2019
·
2 min read
BioMidwest

Centene Corporation Prices Offering of Senior Notes

The Additional 2025 Notes will initially constitute a separate series of notes from the Existing 2025 Notes, but the Company has agreed to exchange the Additional 2025 Notes for additional Existing 2025 Notes, subject to certain conditions.

November 21, 2019
·
12 min read
Lone Star Bio

CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option

The additional shares were sold at the IPO price of $4.00 per share, before underwriting discounts and commissions.

November 21, 2019
·
2 min read
FDA

FDA approves new treatment for adults with partial-onset seizures

XCOPRI is a new option to treat adults with partial-onset seizures, which is an often difficult-to-control condition that can have a significant impact on patient quality of life

November 21, 2019
·
3 min read
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters

At the Company’s 2019 Annual General Meeting held November 5, 2019, shareholders voted in favor of all proposals contained in the Company’s proxy statement dated October 3, 2019

November 21, 2019
·
8 min read
Deals

Onix Health & Life Sciences Division Growing Rapidly to Meet Demand

Leading cloud solutions provider Onix is tripling headcount in its Health & Life Sciences division.

November 21, 2019
·
3 min read
Genetown

Fujifilm Unveils New Digital X-Ray Suites At RSNA

Continues expansion of enhanced imaging technology solutions designed for hospitals and outpatient applications at RSNA

November 21, 2019
·
4 min read